Valuation Eli Lilly and Company

Equities

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			5-day change	1st Jan Change
1,027.51 ^USD	+1.80%		+1.70%	+33.10%

Dec. 12	Health Care Flat on Defensive Bias - Health Care Roundup	DJ
Dec. 12	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	153,067	250,419	347,613	524,224	695,134	920,016	-	-
Change	-	63.6%	38.81%	50.81%	32.6%	32.35%	-	-
Enterprise Value (EV) ¹	165,981	263,395	361,640	546,522	725,355	944,961	930,954	909,264
Change	-	58.69%	37.3%	51.12%	32.72%	30.28%	-1.48%	-2.33%
P/E ratio	24.9x	45.1x	53x	101x	65.9x	44.9x	32.5x	26.9x
PBR	28.6x	29.4x	32.7x	48.9x	49x	33.8x	19.8x	12.8x
PEG	-	-4.57x	4.2x	-6.3x	1x	0.5x	0.8x	1.3x
Capitalization / Revenue	6.24x	8.84x	12.2x	15.4x	15.4x	14.5x	12.1x	10.3x
EV / Revenue	6.76x	9.3x	12.7x	16x	16.1x	14.9x	12.2x	10.2x
EV / EBITDA	19.3x	26.3x	38.2x	63.7x	45.1x	33x	24.8x	20.2x
EV / EBIT	22.8x	31.1x	45.5x	77.4x	50.7x	35.4x	26.7x	21.7x
EV / FCF	32.5x	44.3x	69.1x	690x	193x	84.3x	53.3x	35.7x
FCF Yield	3.08%	2.26%	1.45%	0.15%	0.52%	1.19%	1.88%	2.8%
Dividend per Share ²	2.96	3.4	3.92	4.52	5.2	5.916	6.66	7.392
Rate of return	1.75%	1.23%	1.07%	0.78%	0.67%	0.58%	0.65%	0.72%
EPS ²	6.79	6.12	6.9	5.8	11.71	22.87	31.66	38.24
Distribution rate	43.6%	55.6%	56.8%	77.9%	44.4%	25.9%	21%	19.3%
Net sales ¹	24,540	28,318	28,541	34,124	45,043	63,578	76,298	89,121
EBITDA ¹	8,589	10,005	9,472	8,584	16,079	28,647	37,481	44,977
EBIT ¹	7,265	8,457	7,950	7,057	14,313	26,669	34,805	41,956
Net income ¹	6,194	5,582	6,245	5,240	10,590	20,399	28,048	34,457
Net Debt ¹	12,914	12,976	14,027	22,298	30,221	24,946	10,938	-10,752
Reference price ²	168.84	276.22	365.84	582.92	772.00	1,027.51	1,027.51	1,027.51
Nbr of stocks (in thousands)	906,582	906,592	950,178	899,307	900,432	895,384	-	-
Announcement Date	1/29/21	2/3/22	2/2/23	2/6/24	2/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	44.92x	14.86x	32.99x	0.58%	920B
JOHNSON & JOHNSON	20.19x	5.61x	15.54x	2.44%	510B
ABBVIE INC.	51.11x	7.4x	17.52x	2.92%	395B
ROCHE HOLDING AG	18.38x	4.62x	11.57x	3.12%	340B
ASTRAZENECA PLC	27.04x	5.12x	15.2x	1.8%	278B
NOVARTIS AG	18.3x	4.95x	11.64x	3.08%	254B
MERCK & CO., INC.	12.96x	4.23x	9.08x	3.22%	249B
NOVO NORDISK A/S	13.93x	4.98x	10.31x	3.62%	224B
AMGEN INC.	25.04x	5.94x	10.2x	3.01%	171B
GILEAD SCIENCES, INC.	17.56x	5.55x	10.14x	2.75%	149B
Average	24.94x	6.32x	14.42x	2.65%	349.14B
Weighted average by Cap.	29.64x	7.94x	18.37x	2.24%